Skip to main content

Controversial stem cell patent makes a comeback (New Scientist)

A key patent on human embryonic stem cells (ESCs) is back from the dead – in a form that seems less likely to stifle research.

James Thomson of the University of Wisconsin-Madison isolated the first human ESCs in 1998. This work and earlier experiments with cells from monkeys was covered by three US patents granted to the Wisconsin Alumni Research Foundation.